Skip Navigation

AIDSInfo logo
Home > Search Federal News Releases By Agency > Federal News Releases Search Results

Federal News Releases Search Results

Search Criteria

Keywords: Any
Title: Any
Release Month: Any
Release Year: Any
Topic: Any
Agency: National Institute of Allergy and Infectious Diseases (NIAID)

444 News Releases match your search

  1. National Institutes of Health on National Latino AIDS Awareness Day, October 15, 2008 (Release Date: 10/08/2008)

  2. Study Reveals Link between Apobec3 Gene and Neutralizing Antibody Response to Retrovirus (Release Date: 09/04/2008)

  3. NIAID Will Not Move Forward With The Pave 100 HIV Vaccine Trial (Release Date: 07/17/2008)

  4. NIAID to Advance B-Cell Approach to HIV Vaccines (Release Date: 05/20/2008)

  5. Statement of Anthony S. Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases, on National Asian and Pacific Islander HIV/AIDS Awareness Day, May 19, 2008 (Release Date: 05/19/2008)

  6. Statement of Anthony S. Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases, on HIV Vaccine Awareness Day, May 18, 2008 (Release Date: 05/16/2008)

  7. Statement of Christine F. Sizemore, Ph.D., Barbara E. Laughon, Ph.D., and Anthony S. Fauci, M.D., National Institute of Allergy and Infectious Diseases, National Institutes of Health on World TB Day, March 24, 2008 (Release Date: 03/20/2008)

  8. Statement of Anthony S. Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, on National Native HIV/AIDS Awareness Day, March 20, 2008 (Release Date: 03/20/2008)

  9. tatement of Anthony S. Fauci, M.D. (Release Date: 03/10/2008)

  10. NIAID Scientists Identify New Cellular Receptor for HIV (Release Date: 02/10/2008)

  11. Dr. Carl Dieffenbach Appointed Director of the NIAID Division of AIDS (Release Date: 02/01/2008)

  12. Joint Statement from Drs. Elias Zerhouni, Jack Whitescarver, and Anthony Fauci of the National Institutes of Health on World AIDS Day (Release Date: 11/30/2007)

  13. On the Release of New Data from the HVTN 502 (STEP) HIV Vaccine Study (Release Date: 11/07/2007)

  14. Immunizations Are Discontinued (Release Date: 09/21/2007)

  15. Treating HIV-Infected Infants Early Helps Them Live Longer (Release Date: 07/25/2007)

  16. First Genome-Wide Study of Infectious Disease Opens New Avenues for HIV Treatment, Vaccines (Release Date: 07/19/2007)

  17. Statement of Margaret I. Johnston, Ph.D., Gary J. Nabel, M.D., Ph.D., and Anthony S. Fauci, M.D. National Institute of Allergy and Infectious Diseases National Institutes of Health on HIV Vaccine Awareness Day Friday, May 18, 2007 (Release Date: 05/18/2007)

  18. Statement of Anthony S. Fauci, M.D. Director, National Institute of Allergy and Infectious Diseases National Institutes of Health on National Asian and Pacific Islander HIV/AIDS Awareness Day May 19, 2007 (Release Date: 05/16/2007)

  19. Statement of Christine F. Sizemore, Ph.D., Barbara E. Laughon, Ph.D. and Anthony S. Fauci, M.D., National Institute of Allergy and Infectious Diseases, National Institutes of Health on World TB Day, March 24, 2007 (Release Date: 03/23/2007)

  20. Five Named to NIAID Advisory Council (Release Date: 03/20/2007)

  21. Clinical Trials Units Selected for Newly Restructured HIV/AIDS Clinical Trials Networks (Release Date: 03/12/2007)

  22. Statement of Anthony S. Fauci, M.D. Director, National Institute of Allergy and Infectious Diseases on National Women and Girls HIV/AIDS Awareness Day March 10, 2007 (Release Date: 03/05/2007)

  23. Scientists Unveil Piece of HIV Protein that May Be Key to AIDS Vaccine Development (Release Date: 02/14/2007)

  24. Scientists Sequence Genome of Parasite Responsible for Common Sexually Transmitted Infection (Release Date: 01/11/2007)

  25. Young African American Adults At High Risk for HIV, STDs Even In Absence of High-Risk Behaviors (Release Date: 12/05/2006)

  26. International HIV/AIDS Trial Finds that Risks of Death, AIDS and Other Major Diseases Increase on Episodic Antiretroviral Therapy (Release Date: 11/29/2006)

  27. NIAID Announces New Campaign To Raise Awareness of Preventive HIV Vaccine Research (Release Date: 10/11/2006)

  28. Statement of Anthony S. Fauci, M.D. Director, National Institute of Allergy and Infectious Diseases National Institutes of Health on National Latino AIDS Awareness Day (Release Date: 10/10/2006)

  29. NIAID Announces Leadership for Newly Restructured HIV/AIDS Clinical Trials Networks (Release Date: 06/29/2006)

  30. Monkeys Vaccinated Against SIV (Release Date: 06/09/2006)

  31. World TB Day--Statement of Christine F. Sizemore, Ph.D., Barbara E. Laughon, Ph.D., and Anthony S. Fauci, M.D. (Release Date: 03/21/2006)

  32. Four New Members Named to NIAID Advisory Council (Release Date: 02/13/2006)

  33. National Black HIV/AIDS Awareness and Information Day February 7, 2006 (Release Date: 02/07/2006)

  34. A Large International HIV/AIDS Study Comparing Two Strategies for Management of Anti-Retroviral Therapy (The SMART Study) (Release Date: 01/18/2006)

  35. International HIV/AIDS Trial Finds Continuous Antiretroviral Therapy Superior to Episodic Therapy (Release Date: 01/18/2006)

  36. NIAID Launches First Phase II Trial of a "Global" HIV/AIDS Vaccine--October 11, 2005 (Release Date: 11/11/2005)

  37. Combination Microbicides Protect Monkeys Against HIV-Like Virus (Release Date: 10/31/2005)

  38. http://www3.niaid.nih.gov/about/directors/news/latvax05.htm (Release Date: 10/11/2005)

  39. NIH Mobilizes National, On-Call Volunteer Medical Network in Response to Hurricane Katrina (Release Date: 09/12/2005)

  40. HIV Therapy Greatly Extends Life of Key T Cells, Scientists Find (Release Date: 07/15/2005)

  41. NIAID Funds Center for HIV/AIDS Vaccine Immunology (CHAVI) (Release Date: 07/14/2005)

  42. NIAID Begins Enrolling Volunteers For Novel HIV Vaccine Study (Release Date: 01/24/2005)

  43. NCCC Launches National Perinatal Hotline (Release Date: 12/02/2004)

  44. NIAID Seeks Applicants to Lead Revamped HIV/AIDS Clinical Trials Networks (Release Date: 12/01/2004)

  45. NIAID Statement on National Latino AIDS Day (Release Date: 10/15/2004)

  46. National Latino AIDS Awareness Day (Release Date: 10/15/2004)

  47. Researchers Identify Better Hepatitis C Treatment for People with HIV (Release Date: 07/19/2004)

  48. HIV Patients Get Long-Term Boost with Short, Intermittent Drug Regimen (Release Date: 04/26/2004)

  49. Harmless Virus Associated with Longer Life for Some HIV-Positive Men (Release Date: 03/03/2004)

  50. Scientists Find HIV-Blocking Protein in Monkeys (Release Date: 02/25/2004)

  51. National Black HIV/AIDS Awareness and Information Day - February 7, 2004 (Release Date: 02/05/2004)

  52. RV144, AN ONGOING HIV VACCINE EFFICACY TRIAL IN THAILAND (Release Date: 01/15/2004)

  53. Combination, Order of Anti-HIV Drugs Make a Difference in First-time Recipients (Release Date: 12/10/2003)

  54. Statement of Anthony S. Fauci, M.D. Director, National Institute of Allergy and Infectious Diseases On World AIDS Day (Release Date: 11/28/2003)

  55. Treatment of HIV Infection (Release Date: 10/01/2003)

  56. Nevirapine Sustains Advantage Over AZT During Breastfeeding Period (Release Date: 09/11/2003)

  57. Treatment Interruption Shows No Benefit in Drug-Resistant HIV Infection (Release Date: 08/27/2003)

  58. Revised Guidelines Will Ease Selection of HIV/AIDS Treatments (Release Date: 07/14/2003)

  59. Discovery Lays Groundwork for Potential New Class of Anti-HIV Drugs (Release Date: 03/31/2003)

  60. Important Interim Results from a Phase III, Randomized, Double-Blind Comparison of Three Protease-Inhibitor-Sparing Regimens for the Initial Treatment of HIV Infection (AACTG Protocol A5095) (Release Date: 03/13/2003)

  61. HIV Vaccines Questions and Answers For HIV Prevention Workers (Release Date: 01/01/2003)

  62. HIV Vaccines Questions and Answers For HIV Treatment Advocates (Release Date: 01/01/2003)

  63. Statement of Anthony S. Fauci, M.D. Director, National Institute of Allergy and Infectious Diseases On World AIDS Day (Release Date: 12/01/2002)

  64. Infection by Closely Related HIV Strains Possible (Release Date: 11/27/2002)

  65. Revamped AIDS Web Site Tailored to Diverse Users (Release Date: 11/27/2002)

  66. Major Herpes Vaccine Trial Launched in Women (Release Date: 11/20/2002)

  67. New HIV Vaccine Holds Promise of Global Effectiveness (Release Date: 11/13/2002)

  68. Study Shows Why Some Immune Systems Control HIV (Release Date: 10/09/2002)

  69. HIV/AIDS Statistics (Release Date: 09/01/2002)

  70. HIV Infection and AIDS: An Overview (Release Date: 08/01/2002)

  71. CIPRA Award Supports HIV/AIDS Research in South Africa (Release Date: 07/26/2002)

  72. Exposure to Hepatitis C Has No Effect on Antiretroviral Treatment Outcomes in HIV Patients (Release Date: 07/06/2002)

  73. TIPSHEET XIV International AIDS Conference Barcelona, Spain, July 7-12, 2002 (Release Date: 07/05/2002)

  74. Interagency Agreement Transfers DoD HIV Research to NIAID (Release Date: 07/01/2002)

  75. Award Will Boost HIV/AIDS Research in China (Release Date: 06/28/2002)

  76. Study Concludes Benefits of Anti-HIV Therapy During Pregnancy Outweigh Risks (Release Date: 06/12/2002)

  77. HIV Infection in Adolescents (Release Date: 06/01/2002)

  78. HIV Infection in Minority Populations (Release Date: 06/01/2002)

  79. A New Day for HIV/AIDS Prevention (Release Date: 05/18/2002)

  80. NIAID Teams with Wyeth on HIV/AIDS Vaccine (Release Date: 05/17/2002)

  81. HIV Vaccine Research is "Best Hope" for Controlling AIDS Pandemic, Fifth Annual HIV Vaccine Awareness Day to Highlight Progress, Goals for Future (Release Date: 05/16/2002)

  82. Clinical Research on HIV Vaccines (Release Date: 05/01/2002)

  83. Resources for HIV Vaccine Research and Development (Release Date: 05/01/2002)

  84. Challenges in Designing HIV Vaccines (Release Date: 05/01/2002)

  85. HIV Selectively Suppresses Anti-HIV Defense Cells (Release Date: 05/01/2002)

  86. Review of HIVNET 012 (Release Date: 03/22/2002)

  87. New Awards, Expanded Focus for Pediatric AIDS Clinical Trials Group (Release Date: 03/07/2002)

  88. Genital Herpes (Release Date: 03/01/2002)

  89. NIAID Phase III HIV Vaccine Trial to Determine Correlates of Protection Will Not Proceed Phase III Trial in Thailand to Determine Efficacy Will Be Supported by NIAID through a Combined NIAID-DoD Program (Release Date: 02/25/2002)

  90. NIAID'S HIV Vaccine Trials Network (HVTN) (Release Date: 02/01/2002)

  91. The SMART Way to Fight AIDS (Release Date: 01/10/2002)

  92. Treatment of HIV Infection (Release Date: 01/01/2002)

  93. NIAID and Merck to Collaborate on HIV Vaccine Development (Release Date: 12/20/2001)

  94. New Findings Explain T-cell Loss in HIV Infection (Release Date: 12/10/2001)

  95. Garlic Supplements Can Impede HIV Medication (Release Date: 12/05/2001)

  96. 7-Day-On, 7-Day-Off Regimen Could Reduce Cost, Toxicities of HIV Therapy (Release Date: 12/03/2001)

  97. Comprehensive International Program of Research on AIDS (Release Date: 12/01/2001)

  98. New NIH Web Resource Marks World AIDS Day (Release Date: 11/30/2001)

  99. New Finding May Help Doctors Prevent HIV Drug Resistance (Release Date: 11/22/2001)

  100. HIV "Rides" into Cells on Membrane Rafts, NIAID Scientists Determine (Release Date: 11/19/2001)

  101. High HIV Levels Shut Down Anti-HIV Immune Responses (Release Date: 11/19/2001)

  102. First AIDS Vaccine Made at NIAID's Vaccine Research Center Enters Clinical Trial (Trial Begins Just One Year after Laboratories Open) (Release Date: 10/09/2001)

  103. How HIV Causes AIDS (Release Date: 10/01/2001)

  104. Major AIDS Studies to Increase Minority Enrollment, Answer New Questions (Release Date: 09/10/2001)

  105. Fauci to Present AIDS Vaccine Update at Philadelphia Meeting: Accelerated Commitment to Research Has Led to Important Advances (Release Date: 09/04/2001)

  106. NIAID Researchers Identify HIV-Induced Changes in B Cells (Release Date: 08/14/2001)

  107. Dr. Edmund C. Tramont Named Director of NIAID's Division of AIDS (Release Date: 07/16/2001)

  108. NIAID Pediatric AIDS Clinical Trial Units (Release Date: 07/01/2001)

  109. NIH Launches Online AIDS Oral History Project (Release Date: 06/04/2001)

  110. Fourth Annual HIV Vaccine Awareness Day Honors Volunteers, Promotes Research (Release Date: 05/14/2001)

  111. A Parasite, a Virus, and a Bacterium: NIAID's Plan to Tackle the World's Leading Killers (Release Date: 05/07/2001)

  112. HIV Infection in Women (Release Date: 05/01/2001)

  113. NIAID's HIV Prevention Trials Network (HPTN) (Release Date: 04/01/2001)

  114. New Prime-Boost HIV Vaccine Strategy Shows Promise in Monkeys (Release Date: 03/08/2001)

  115. Study Confirms Gender Differences in Progression from HIV to AIDS: Despite Differences in "Viral Load," Men and Women Develop AIDS at the Same Rate (Release Date: 03/07/2001)

  116. Human Papillomavirus and Genital Warts (Release Date: 03/01/2001)

  117. Mother-to-Infant HIV Transmission Rate Less Than 2% in Phase III Perinatal Trial (Release Date: 02/08/2001)

  118. HIV Treatment Guidelines Updated for Adults and Adolescents (Release Date: 02/05/2001)

  119. What You Should Know About Hepatitis C (Release Date: 01/18/2001)

  120. NIH Scientists Highlight Role of Macrophages in HIV Infection (Release Date: 01/01/2001)

  121. World AIDS Day 2000: NIH Announces New Plan for Global AIDS Research (Release Date: 11/30/2000)

  122. The Evidence That HIV Causes AIDS (Release Date: 11/29/2000)

  123. T Cell's Internal "Housekeeping Service" Plays Role in HIV Infection (Release Date: 11/20/2000)

  124. Researchers Identify New Genetic Risk Factor for HIV Infection (Release Date: 11/15/2000)

  125. Interleukin-2 May Help Patients With Advanced HIV Disease, New Study Shows (Release Date: 10/25/2000)

  126. Promising HIV Vaccine Strategy Identified in Monkey Studies (Release Date: 09/20/2000)

  127. NIH STUDY DEMONSTRATES SURPRISING COMPLICATION IN HIV INFECTION (Release Date: 09/08/2000)

  128. B Cells May Help Maintain HIV Infection (Release Date: 08/29/2000)

  129. Inexpensive AIDS Drug Still Reduces HIV Transmission from Mother to Child After One Year (Release Date: 07/13/2000)

  130. NIH ANNOUNCES NEW INTERNATIONAL NETWORK TO STUDY HIV PREVENTION STRATEGIES (Release Date: 07/12/2000)

  131. FAUCI PRESENTS NEW DATA ON STRUCTURED INTERMITTENT THERAPY AT XIIITH WORLD AIDS CONFERENCE IN DURBAN, SOUTH AFRICA (Release Date: 07/11/2000)

  132. UPDATE ON CLINICAL TRIALS OF INTERLEUKIN-2 (IL-2) AS IMMUNE-BASED THERAPY FOR HIV (Release Date: 07/08/2000)

  133. NIAID Public-Private Partnerships Seek to Develop HIV/AIDS Vaccine (Release Date: 06/27/2000)

  134. NIAID Creates Global Network to Advance Development of HIV Vaccines (Release Date: 05/25/2000)

  135. Third Annual HIV Vaccine Awareness Day Honors Volunteers, Promotes Research (Release Date: 05/15/2000)

  136. HIV Vaccine Glossary (Release Date: 05/01/2000)

  137. NIH Researchers Zero in on Viral Changes That Lead to Chronic Hepatitis C (Release Date: 04/13/2000)

  138. Low Blood Levels of HIV Reduce Risk of Heterosexual Transmission (Release Date: 03/29/2000)

  139. NIAID Researchers Discover Why Some HIV-Infected People Don't Develop AIDS (Release Date: 03/15/2000)

  140. NIAID Releases "The Jordan Report 2000: Accelerated Development of Vaccines" (Release Date: 03/02/2000)

  141. NIAID Topical Microbicide Research Developing New Tools to Protect Women from HIV/AIDS and Other STDs (Release Date: 03/01/2000)

  142. Backgrounder - HIV Infection in Infants and Children (Release Date: 02/01/2000)

  143. Newly Updated HIV Treatment Guidelines for Adults and Adolescents Available on the World Wide Web (Release Date: 01/28/2000)

  144. Molecular Traffic Signal Could Be New HIV Drug Target (Release Date: 12/08/1999)

  145. NIAID Renews Funding for the Adult AIDS Clinical Trials Group (Release Date: 11/02/1999)

  146. NIAID: Planning for the 21st Century (Release Date: 11/01/1999)

  147. NIAID Study: Rapid Rebound of HIV and Reappearance of HIV Reservoirs in Patients Treated with IL-2 and Combination Antiretroviral Drugs Following Cessation of Therapy (Release Date: 10/27/1999)

  148. New Model Suggests That AIDS Drugs May Not Abolish HIV Infection (Release Date: 10/06/1999)

  149. Mother-to-Infant HIV Transmission - Quick Facts (Release Date: 09/16/1999)

  150. Hepatitis C Conference for the Generalist and Specialist (Release Date: 09/02/1999)

  151. Study Finds HIV Breastfeeding Risk Highest in Early Months After Birth (Release Date: 08/24/1999)

  152. Fusion-competent vaccine: An immunogen that induces a potent, broadly reactive anti-HIV neutralizing response in mice (Release Date: 08/23/1999)

  153. Dr. Carole Heilman Named Director of NIAID's Division of Microbiology and Infectious Diseases (Release Date: 07/26/1999)

  154. Combination HIV Vaccine Induces Diverse Immune Responses (Release Date: 07/13/1999)

  155. Alteration in Cell Death Pathway Sheds Light on Autoimmune Disease (Release Date: 07/08/1999)

  156. HIVNET 012 Questions and Answers (Release Date: 07/08/1999)

  157. NIAID Launches Major Step in Trial of Experimental Shingles Vaccine (Release Date: 06/15/1999)

  158. NIAID Launches Major Step in Trial of Experimental Shingles Vaccine (Release Date: 06/15/1999)

  159. Facts About Shingles (Varicella-Zoster Virus) (Release Date: 06/01/1999)

  160. Information About the Shingles Prevention Study (Release Date: 06/01/1999)

  161. New Anti-HIV Therapies Needed To Eradicate HIV (Release Date: 05/26/1999)

  162. Second Annual AIDS Vaccine Day Honors Volunteers Nationwide (Release Date: 05/13/1999)

  163. Newly Updated HIV Treatment Guidelines for Adults and Adolescents Available on the World Wide Web (Release Date: 05/05/1999)

  164. Immune Response to Hepatitis B Spares Liver Cells (Release Date: 04/29/1999)

  165. NIAID Renews Funding for Multicenter AIDS Cohort Study (Release Date: 04/20/1999)

  166. IOM Report Offers New Look at U.S. Vaccine Priorities (Release Date: 04/08/1999)

  167. Dr. Gary Nabel Named Director of NIH Vaccine Research Center (Release Date: 03/11/1999)

  168. HHS Secretary Names Five to NIAID Advisory Council (Release Date: 02/26/1999)

  169. NIAID Opens First AIDS Vaccine Trial in Africa (Release Date: 02/08/1999)

  170. New Studies Offer Clues to AIDS Vaccine Design and Safety (Release Date: 02/01/1999)

  171. NIAID-Supported Scientists Discover Origin of HIV-1 (Release Date: 01/31/1999)

  172. Culturally Relevant Behavioral Intervention Dramatically Reduces STDs (Release Date: 01/13/1999)

  173. Reassuring Findings About Infants Exposed to Zidovudine (Release Date: 01/12/1999)

  174. Study Offers Hope for Immune Reconstitution after HIV Infection (Release Date: 12/16/1998)

  175. Treatment With IL-2 Plus HAART Markedly Reduces HIV in Immune System 'Hiding Places' (Release Date: 11/15/1998)

  176. Study Finds Less Intensive Treatments may not Maintain HIV Suppression (Release Date: 10/28/1998)

  177. Reduction in U.S. HIV-Related Deaths, 1996 to 1997: Statement of Anthony S. Fauci, Director National Institute of Allergy and Infectious Diseases National Institutes of Health (Release Date: 10/07/1998)

  178. Study Shows Efavirenz Promising in Treating Pediatric HIV Infection: Leads to Approval of New Drug for Treating HIV-infected Children (Release Date: 09/28/1998)

  179. NIAID Scientists Discover HIV Disease-Slowing Mutation (Release Date: 09/23/1998)

  180. NIAID Announces funding for 12 Centers for AIDS Research (Release Date: 09/01/1998)

  181. NIAID Collaborates with VaxGen on Vaccine Studies (Release Date: 08/18/1998)

  182. Results of Simplified Screening for Chlamydia in Female Military Recruits Suggest Testing for All Sexually Active Young Women (Release Date: 08/09/1998)

  183. Dr. Peggy Johnston Rejoins NIAID to Lead AIDS Vaccine R&D Effort (Release Date: 07/28/1998)

  184. Pool of Latently Infected, 'Resting' Cells Established Early in HIV Infection (Release Date: 07/20/1998)

  185. Syphilis Genome Sequence Offers Clues to Better Diagnosis, Prevention and Treatment (Release Date: 07/16/1998)

  186. The Perils of Discontinuing Therapy: Without HAART, Cytokines Stimulate HIV From Latently Infected Cells (Release Date: 07/06/1998)

  187. Scientists Make Progress Toward Gene Therapy for HIV Infection (Release Date: 07/01/1998)

  188. Fauci to Present New Insights into HIV Latency at 12th World AIDS Conference (Release Date: 06/30/1998)

  189. Crystal Structure of Key HIV Protein Reveals New Prevention, Treatment Targets (Release Date: 06/17/1998)

  190. Interleukin-12 Helps Control Mycobacterium Avium Infection (Release Date: 06/01/1998)

  191. Mass Treatment for Curable STDs has Mixed Results, Study Finds: Some STD Rates Fall, but HIV Incidence Remains Unchanged (Release Date: 06/01/1998)

  192. Communities Honor HIV/AIDS Vaccine Volunteers (Release Date: 05/13/1998)

  193. Short-Course TB Prophylaxis Effective in HIV-Infected Individuals (Release Date: 02/11/1998)

  194. Fauci: New Findings Help Explain 'Rebound' of HIV in Patients Who Discontinue Triple-Drug Therapy Data Suggest Strategies to Purge Latently Infected Cells (Release Date: 02/02/1998)

  195. Novel Concepts Put to the Test in Three New AIDS Vaccine Trials (Release Date: 01/29/1998)

  196. Chickenpox (Release Date: 01/01/1998)

  197. Enzyme Protects Virus from Enviromental Hazards (Release Date: 01/01/1998)

  198. Studies Shed New Light on HIV Epidemic in India (Release Date: 12/16/1997)

  199. HIV Persists and Can Replicate Despite Prolonged Combination Therapy (Release Date: 11/13/1997)

  200. Pelvic Inflammatory Disease (Release Date: 11/01/1997)

  201. HIV Subterfuge Revealed (Release Date: 10/29/1997)

  202. Scientists Develop Powerful Tool for Studying TB. (Release Date: 09/29/1997)

  203. First Grants for Innovative AIDS Vaccine Research Awarded (Release Date: 09/29/1997)

  204. Live, Attenuated AIDS Vaccines (Release Date: 09/25/1997)

  205. Mutant Gene Not Sole Explanation for HIV Non-Progression (Release Date: 09/15/1997)

  206. Trojan Horse Virus Controls HIV Infection (Release Date: 09/04/1997)

  207. Preventing Perinatal Infections -- For Pennies (Release Date: 08/19/1997)

  208. Researchers Clone Infectious Hepatitis C Virus (Release Date: 07/24/1997)

  209. Phase II Prime-Boost HIV Vaccine Trial (AVEG 202/HIVNET 014) Questions and Answers (Release Date: 06/30/1997)

  210. TB Prophylaxis Unnecessary in HIV-Infected People with Anergy, Study Suggests (Release Date: 06/30/1997)

  211. NIAID Funds Scientists to Study Acute Infection and Early HIV Disease (Release Date: 06/26/1997)

  212. Two Drugs Better Than One for Treating Children with Symptomatic HIV (Release Date: 06/26/1997)

  213. Draft HIV/AIDS Treatment Guidelines Available (Release Date: 06/19/1997)

  214. Study Of Low-dose Oral Alpha Interferon Closes (Release Date: 06/13/1997)

  215. Limited Course Of Thalidomide Effective In Treating Aids-related Mouth Ulcers (Release Date: 05/21/1997)

  216. Study Shows That Doxil is Highly Effective and Safe in the Treatment of Advanced Kaposi's Sarcoma (Release Date: 05/20/1997)

  217. Study Provides Baseline Measurements of Viral Load in Pediatric AIDS (Release Date: 05/07/1997)

  218. HIV Wasting Syndrome (Release Date: 05/01/1997)

  219. HIV Prevention Efficacy Trials (Release Date: 05/01/1997)

  220. HIV Vaccine Volunteer Update (Release Date: 05/01/1997)

  221. CD4+ T Cell Diversity, Lost in Late-Stage HIV Disease, Is Not Immediately Restored by Therapy (Release Date: 04/29/1997)

  222. NIAID Evaluates N-9 Film as Microbicide (Release Date: 04/03/1997)

  223. Pediatric AIDS Overview (Release Date: 04/01/1997)

  224. NIAID Resources for Studying HIV/AIDS in Women (Release Date: 04/01/1997)

  225. STATEMENT ON ACTG PROTOCOL 185 (Release Date: 03/25/1997)

  226. IL-2 Injections Safely Boost CD4+ T Cell Levels in HIV-Infected Patients (Release Date: 03/24/1997)

  227. New Grant Program Encourages Innovative AIDS Vaccine Research (Release Date: 03/05/1997)

  228. Mycobacterium Avium Complex (Release Date: 03/01/1997)

  229. Complejo Mycobacterium Avium (Release Date: 03/01/1997)

  230. Tuberculosis (Release Date: 03/01/1997)

  231. NIAID Funds Pediatric AIDS Clinical Trials Group (Release Date: 02/25/1997)

  232. Study Confirms that Combination Treatment Using a Protease Inhibitor Can Delay HIV Disease Progression and Death (Release Date: 02/24/1997)

  233. Pediatric AIDS Clinical Trials Group: Questions and Answers Concerning the Competitive Renewal (Release Date: 02/01/1997)

  234. Clinical Trials for AIDS Therapies (Release Date: 02/01/1997)

  235. ACTG 315 Preliminary Results: Drug Cocktail Restores Partial Immune Function (Release Date: 01/27/1997)

  236. Scientists to Discuss Chemokine Receptor Research (Release Date: 01/23/1997)

  237. Fauci Lab Presents New Data on AIDS Pathogenesis, Treatment at Retroviruses Conference (Release Date: 01/22/1997)

  238. NIAID Scientists Win Prize for Top Science Paper (Release Date: 01/16/1997)

  239. Primary Immune Response to HIV Predicts Disease Progression (Release Date: 01/09/1997)

  240. HIV/AIDS VACCINE AND PREVENTION STRATEGIES: NIAID Resources for Research and Development (Release Date: 01/01/1997)

  241. Fauci: New Findings on Host Factors Illuminate AIDS Pathogenesis (Release Date: 12/11/1996)

  242. New ACTG 076 Analysis Emphasizes Importance of Offering AZT Therapy to All HIV-Infected Pregnant Women (Release Date: 11/27/1996)

  243. Important Information on the Combination of Zidovudine (ZDV) and Stavudine (d4T) in ZDV-experienced HIV-Infected Patients (Release Date: 11/22/1996)

  244. NIAID Statement (Release Date: 11/08/1996)

  245. IL-2 Therapy Doubles CD4+ T Cell Counts in HIV-Infected People (Release Date: 10/30/1996)

  246. ACTG 175, CPCRA 007 Trial Results Published (Release Date: 10/09/1996)

  247. Mutant Gene Blocks HIV's Entry Into Cells (Release Date: 09/01/1996)

  248. PHS Issues Guidelines for Treating Occupational Exposure to HIV (Release Date: 09/01/1996)

  249. Volunteers Sought for HIV Treatment Study (Release Date: 09/01/1996)

  250. Interleukin-2 Continues to Show Promise as HIV Therapy (Release Date: 09/01/1996)

  251. Drug Combo Safe for HIV-Infected Children (Release Date: 09/01/1996)

  252. Nevirapine Approved by FDA: First non-nucleoside reverse transcriptase inhibitor (Release Date: 09/01/1996)

  253. CRCRA Researchers Present OI Studies at Vancouver (Release Date: 09/01/1996)

  254. Couples Study in Haiti Shows Reduction in Heterosexual HIV Transmission (Release Date: 08/26/1996)

  255. NIH-Sponsored Study Stopped: New Drug Does Not Control AIDS-Related Eye Disease (Release Date: 08/15/1996)

  256. New Insights into AIDS-Associated Skin Disease (Release Date: 08/08/1996)

  257. TB Increases HIV Replication in HIV-Infected People (Release Date: 08/01/1996)

  258. New Concept to Improve Live-Attenuated HIV Vaccines (Release Date: 07/24/1996)

  259. Important Therapeutic Information on the Dosing of Clarithromycin for the Treatment of Disseminated Mycobacterium avium Complex (DMAC) Infection in HIV-Infected Patients (Release Date: 07/23/1996)

  260. NIAID-Supported Researchers Illuminate 3-D Structure of HIV Protein (Release Date: 07/12/1996)

  261. NIAID Study Rules Out High-Dose Clarithromycin for AIDS-Related MAC (Release Date: 07/10/1996)

  262. IL-2 Therapy: Encouraging Data on Quality of Life Reported for Immune-Boosting Drug (Release Date: 07/10/1996)

  263. Fluconazole Prevents Yeast Infections in Women with HIV (Release Date: 07/10/1996)

  264. Interleukin-2 Injections Produce Dramatic, Sustained Increases in CD4+ T Cell Counts in Patients with Early-Stage HIV Disease (Release Date: 07/10/1996)

  265. NIAID Study Finds Initial Intermittent Treatment Effective for HIV-Related TB (Release Date: 07/09/1996)

  266. A Delicate Balance: Levels of HIV Replication are Strongly Influenced by Interaction of Positive and Negative Host Factors (Release Date: 07/09/1996)

  267. AIDS Vaccine Research Highlights (Release Date: 07/09/1996)

  268. NIAID Researchers Identify Second Fusion Cofactor for HIV (Release Date: 06/19/1996)

  269. Studies Shed New Light on Mother-to-Infant HIV Transmission (Release Date: 06/19/1996)

  270. Increased Risk of Cervical Abnormalities Among HIV-Infected African Women (Release Date: 06/01/1996)

  271. Antiretrovirals Plus Immunomodulators: Didanosine/Interferon-alpha Combination Shows Promise (Release Date: 06/01/1996)

  272. MACS Study: HIV RNA Levels Predict Clinical Outcome (Release Date: 05/23/1996)

  273. Chlamydia Screening May Reduce Pelvic Inflammatory Disease Rates (Release Date: 05/22/1996)

  274. NIAID Researchers Identify Cofactor for Entry of HIV into Cells (Release Date: 05/09/1996)

  275. Gene Therapy Prolongs CD4+ T Cell Survival in HIV-Infected Individuals (Release Date: 04/01/1996)

  276. Two New Protease Inhibitors Approved By FDA: NIAID Research Was Pivotal to Development of New Class of Drugs (Release Date: 04/01/1996)

  277. Dos nuevos inhibidores de proteasas fueron aprobaron por la FDA: La investigación llevada a cabo por NIAID fue esencial para el desarrollo de una clase nueva de medicamentos (Release Date: 04/01/1996)

  278. Low-Dose Oral Alpha Interferon Study Opens (Release Date: 04/01/1996)

  279. Vaccines in Clinical Trials (Release Date: 04/01/1996)

  280. Tuberculosis Tip-Sheet (Release Date: 03/22/1996)

  281. CPCRA 007: Preliminary Results of Combination Antiretroviral Study (Release Date: 03/01/1996)

  282. ACTG 152: New Insights Into Pediatric Antiretroviral Therapy (Release Date: 03/01/1996)

  283. Studies Examine Relationship of Viral Load to Maternal HIV Transmission (Release Date: 03/01/1996)

  284. Highlights of AIDS Vaccine Meeting (Release Date: 03/01/1996)

  285. Journal Watch (Release Date: 03/01/1996)

  286. ACTG PROTOCOL 152: Questions and Answers (Release Date: 02/28/1996)

  287. ACTG 152: Efficacy and Safety Study Results (Release Date: 02/28/1996)

  288. Fauci to Present NIAID Strategy for HIV Vaccine Development (Release Date: 02/12/1996)

  289. NIAID AIDS Vaccine Evaluation Units (Release Date: 02/01/1996)

  290. Where Do HIV/AIDS Drugs Come From? (Release Date: 02/01/1996)

  291. Anthony S. Fauci to Present New Data on HIV Escape Mechanisms and HIV Suppressor Molecules (Release Date: 01/28/1996)

  292. Adult AIDS Clinical Trials Group: Questions and Answers Concerning the Competitive Renewal. (Release Date: 11/30/1995)

  293. NIAID HIV/AIDS Vaccine Research and Development Strategy and Opportunity (Release Date: 11/30/1995)

  294. NIAID Funds Adult AIDS Clinical Trials Group (Release Date: 11/30/1995)

  295. Drug Completely Protects Monkeys Exposed to SIV (Release Date: 11/16/1995)

  296. Thalidomide Effective Treatment for AIDS-Related Mouth Ulcers (Release Date: 10/31/1995)

  297. HIV Trapped in Lymph Nodes Infectious Despite Antibodies (Release Date: 10/25/1995)

  298. Volunteers Needed for Study of HIV Viral Load Test (Release Date: 10/12/1995)

  299. ACTG 175: Anti-HIV Therapy Lowers Risk of AIDS, Death in Patients with Intermediate-Stage HIV Disease. (Release Date: 09/14/1995)

  300. Questions and Answers: AIDS Clinical Trials Group (ACTG) 175 (Release Date: 09/14/1995)

  301. NIAID Funds STD Research (Release Date: 09/09/1995)

  302. Primary Immune Deficiency: Key Facts for Physicians and Patients (Release Date: 09/01/1995)

  303. CPCRA CMV Study CPCRA 023: Questions and Answers. (Release Date: 08/28/1995)

  304. The Relationship between the Human Immunodeficiency Virus and the Acquired Immunodeficiency Syndrome (Part I) (Release Date: 07/24/1995)

  305. The Relationship between the Human Immunodeficiency Virus and the Acquired Immunodeficiency Syndrome (Part II) (Release Date: 07/24/1995)

  306. HIV and AIDS (Release Date: 07/01/1995)

  307. NIAID Launches Three New AIDS Vaccine Trials (Release Date: 06/13/1995)

  308. NIAID Tuberculosis Research (Release Date: 05/01/1995)

  309. Cytomegalovirus (CMV) Retinitis (Release Date: 05/01/1995)

  310. NIAID Expands Research on Topical Microbicides to Prevent STDs in Women (Release Date: 04/27/1995)

  311. AIDS-Related Diarrhea (Release Date: 04/01/1995)

  312. HIV-Related Candidiasis (Release Date: 04/01/1995)

  313. HIV/AIDS Study in Homosexual Men Renewed (Release Date: 03/30/1995)

  314. Clearance of HIV Infection in Infant (Release Date: 03/29/1995)

  315. Therapies for AIDS-Related Infections--Two Studies Published (Release Date: 03/14/1995)

  316. Questions and Answers about the NIAID Interleukin-2 Study (Release Date: 03/01/1995)

  317. Interleukin-2 Produces Significant, Sustained Increases in CD4+ T Cells in HIV-Infected People (Release Date: 03/01/1995)

  318. La Meningitis Criptococócica (Release Date: 03/01/1995)

  319. La Retinitis Causada Por el Citomegalovirus (CMV) (Release Date: 03/01/1995)

  320. Toxoplasmosis (Release Date: 03/01/1995)

  321. Pulmonía Pneumocystis Carinii (PCP) (Release Date: 03/01/1995)

  322. HIV Vaccine Preparedness Study (Release Date: 03/01/1995)

  323. Cytomegalovirus Infection (Release Date: 03/01/1995)

  324. Tuberculosis Relacionada con el VIH (Release Date: 03/01/1995)

  325. Complicaciones Neurológicas Relacionadas con el VIH (Release Date: 03/01/1995)

  326. Histoplasmosis (Release Date: 03/01/1995)

  327. La Diarrea Relacionada con el SIDA (Release Date: 03/01/1995)

  328. Candidiasis Relacionada con el VIH (Release Date: 03/01/1995)

  329. Tipos de Cáncer Relacionados con el SIDA (Release Date: 03/01/1995)

  330. ARAC Reaffirms Need for Low-Dose Oral Alpha Interferon Study (Release Date: 02/24/1995)

  331. The World as a Hot Zone: New and Re-Emerging Diseases (Release Date: 02/21/1995)

  332. Social Changes Needed to Control AIDS Pandemic (Release Date: 02/20/1995)

  333. Malicious Microbes Warrant Basic Biomedical Research (Release Date: 02/20/1995)

  334. Chimpanzee Vaccine Model Protects Against HIV-1 Infection (Release Date: 02/01/1995)

  335. Gene Therapy for HIV Infection (Release Date: 02/01/1995)

  336. Progress in HIV Vaccine Development Discussed (Release Date: 02/01/1995)

  337. Drug-Sensitive HIV Could Make Safer AIDS Vaccine (Release Date: 01/31/1995)

  338. Dendritic Cells: A Key to Early HIV Infection (Release Date: 01/30/1995)

  339. Fauci: Host Factors Key to Control of HIV Infection (Release Date: 01/30/1995)

  340. NIAID Researchers Report New Data on Non-Progressive HIV Infection (Release Date: 01/25/1995)

  341. What's What in NIAID-Supported HIV Vaccine Research (Release Date: 01/01/1995)

  342. Terry Beirn Community Programs for Clinical Research on AIDS (Release Date: 01/01/1995)

  343. NIAID Research on AIDS (Release Date: 01/01/1995)

  344. La Infección Por el VIH y el SIDA (Release Date: 12/01/1994)

  345. Neurologic Complications of HIV (Release Date: 11/01/1994)

  346. Histoplasmosis (Release Date: 11/01/1994)

  347. AIDS-Related Cancers (Release Date: 11/01/1994)

  348. HIV-Related Tuberculosis (Release Date: 11/01/1994)

  349. ACTG 241: Executive Summary (Release Date: 11/01/1994)

  350. NIAID Trial of Triple Drug Combination for HIV Infection Closes (Release Date: 11/01/1994)

  351. Toxoplasmosis (Release Date: 11/01/1994)

  352. Pneumocystis carinii pneumonia (PCP) (Release Date: 11/01/1994)

  353. Cryptococcal Meningitis (Release Date: 11/01/1994)

  354. HIV Damage of Nervous System Increases (Release Date: 10/27/1994)

  355. Test for HIV Viral Burden Promising in Clinical Setting (Release Date: 10/26/1994)

  356. First Successful Vaccine Against Hepatitis E Protects Against Disease (Release Date: 10/10/1994)

  357. Kidney Transplantation in Children Examined (Release Date: 10/06/1994)

  358. Gene Therapy Feasible for Immune Disorder (Release Date: 10/05/1994)

  359. NIAID Mobilizes Teams of Scientists to Advance Novel AIDS Therapies (Release Date: 09/01/1994)

  360. Sites Awarded, Renewed for Community-Based AIDS Trials (Release Date: 09/01/1994)

  361. HIV Burden Unchecked by Antiretroviral Therapy In Early Stage Disease (Release Date: 08/08/1994)

  362. Host Factors Help Determine Progress of HIV Disease (Release Date: 08/08/1994)

  363. Hepatitis C Virus Mutates to Escape Human Immune System (Release Date: 08/01/1994)

  364. NIAID Expands HIV Vaccine Clinical Trial Sites (Release Date: 07/01/1994)

  365. NIAID Advisors Recommend Continuing But Not Expanding at This Time Ongoing Trials of Two Candidate HIV Vaccines (Release Date: 06/17/1994)

  366. Many New Tuberculosis Cases Recently Acquired (Release Date: 06/15/1994)

  367. Treating Genital Herpes Shows Promise in NIAID Study (Release Date: 06/13/1994)

  368. HIV Infection in Vaccine Trial Volunteers (Release Date: 06/01/1994)

  369. ACTG 229: Antiviral Trial of Combination Therapy (Release Date: 05/31/1994)

  370. ACTG 229: Executive Summary (Release Date: 05/26/1994)

  371. Interferon Gamma Boosts Ability to Fight Drug-Resistant Mycobacterial Infections (Release Date: 05/11/1994)

  372. Scientific Review Supports Expanded Clinical Studies of two Candidate HIV Vaccines (Release Date: 04/29/1994)

  373. Dr. John Y. Killen Named Director of NIAID's Division of AIDS (Release Date: 04/17/1994)

  374. HIV/AIDS Vaccines (Release Date: 04/01/1994)

  375. AIDS AND OPPORTUNISTIC INFECTIONS (Release Date: 04/01/1994)

  376. NIAID To Fund Centers for AIDS Research (Release Date: 03/03/1994)

  377. Important Therapeutic Information on the Benefit of Zidovudine for the Prevention of the Transmission of HIV from Mother to Infant (Release Date: 02/22/1994)

  378. AZT Reduces Rate of Maternal Transmission of HIV (Release Date: 02/21/1994)

  379. ACTG 076 Questions and Answers (Release Date: 02/20/1994)

  380. Executive Summary: Abstract ACTG 076. A Phase III Randomized, Placebo-Controlled Trial to Evaluate the Efficacy, Safety and Tolerance of Zidovudine (ZDV) for the Prevention of Maternal-Fetal Transmission (Release Date: 02/20/1994)

  381. Primary Therapy Prevents Initial Bout of PCP (Release Date: 12/15/1993)

  382. Fluconazole Delays Fungal Infections In AIDS Patients (Release Date: 12/15/1993)

  383. Acyclovir-Resistant Genital Herpes Found in Person with Healthy Immune System (Release Date: 12/08/1993)

  384. ACTG Assessment: Organization and Management (Release Date: 12/01/1993)

  385. HIV Therapy Recommendations Issued (Release Date: 12/01/1993)

  386. Hope for High-Risk Infants: New Treatment Safe, Effective in Preventing Dangerous Respiratory Infection (Release Date: 11/17/1993)

  387. Future NIAID AIDS Treatment Strategies Will Be Based on Greater Understanding of HIV Disease Mechanisms (Release Date: 11/11/1993)

  388. Parasites in the United States Affect Millions (Release Date: 11/01/1993)

  389. Fauci: AIDS Therapies Must Address Complexity of HIV Disease Process (Release Date: 10/18/1993)

  390. Researchers Examine Possible Effects of Silicone on the Immune Response (Release Date: 10/17/1993)

  391. NIAID HIV Vaccine Trials Update (Release Date: 10/10/1993)

  392. AIDS Vaccines Contracts Pave Way for Large National and International Studies (Release Date: 10/10/1993)

  393. Nine U.S. Sites Selected For Study of Early, Primary HIV Infection (Release Date: 10/05/1993)

  394. Task Force Issues Prevention and Treatment Recommendations for AIDS-related MAC (Release Date: 09/15/1993)

  395. Two Studies Examine Drugs to Prevent HIV-Associated Opportunistic Infections (Release Date: 07/26/1993)

  396. Immunity Without T Cells: NIAID Researchers Illuminate Role of Interleukin-12 (Release Date: 06/30/1993)

  397. HIV Therapy Guidelines Issued (Release Date: 06/25/1993)

  398. Syndrome of CD4+ T Cell Suppression Without HIV Infection Rare, Occurs in Many Forms (Release Date: 06/11/1993)

  399. Relative Benefit of ddI and AZT Depends on Duration of Patients' Previous AZT Use (Release Date: 06/10/1993)

  400. The Effectiveness of AZT Alone, ddC Alone or AZT/ddC Combination Is Similar Overall For Patients with Advanced HIV Disease (Release Date: 06/10/1993)

  401. Trial of TAT Antagonist as Therapy for HIV Infection Altered (Release Date: 06/10/1993)

  402. Young Gay Men Not Heeding AIDS Message, Rates of Infection Remains High (Release Date: 06/09/1993)

  403. NIAID Combats Tuberculosis on Many Fronts (Release Date: 06/09/1993)

  404. AIDS Survival Time Nearly Doubles Since 1984 (Release Date: 06/08/1993)

  405. ACTG 116B/117: High Levels of AZT Resistance May Predict HIV Disease Progression (Release Date: 06/08/1993)

  406. AIDS Treatment Strategies Must Address Multi-Dimensional Nature of HIV Disease (Release Date: 06/07/1993)

  407. HIV and AIDS Research: IX International Conference on AIDS Highlights (Release Date: 06/01/1993)

  408. Women and HIV, IX International Conference on AIDS Highlights (Release Date: 06/01/1993)

  409. Clinical Trials of HIV/AIDS Vaccines IX International Conference on AIDS Highlights (Release Date: 06/01/1993)

  410. HIV Infection Among Gay and Bisexual Men IX International Conference on AIDS Highlights (Release Date: 06/01/1993)

  411. Variations in Response to HIV Exposure and Infection: Long- Term Survivors and Others (Release Date: 06/01/1993)

  412. Atovaquone Effective, Well-Tolerated Treatment for AIDS-Related Pneumonia (Release Date: 05/26/1993)

  413. AIDS Clinical Trial Tests Acupuncture and Amitriptyline for Pain Relief (Release Date: 05/25/1993)

  414. NIAID Opens Combination Therapy Trial for HIV Infection (Release Date: 05/25/1993)

  415. Glow-in-the-Dark Assay Illuminates TB Diagnosis (Release Date: 05/06/1993)

  416. Concorde Trial (Release Date: 04/01/1993)

  417. NIAID Launches HIV Therapy Trial of Protease Inhibitor (Release Date: 03/26/1993)

  418. HIV Disease is Active and Progressive in Lymphoid Organs During Clinical Latency, NIAID Researchers Report (Release Date: 03/24/1993)

  419. NIAID Begins Study of New Drug for HIV Infection (Release Date: 03/22/1993)

  420. Results of Trial of ddI in Patients Intolerant of AZT Announced (Release Date: 02/26/1993)

  421. NIAID Begins First Test of Novel HIV Peptide Vaccine (Release Date: 02/12/1993)

  422. Features of CD4+ T Cell Suppression Identified Among People Without HIV Infection (Release Date: 02/10/1993)

  423. Important Therapeutic Information on Treatment of HIV Infection in HIV-Infected Patients Who Are Intolerant of or Have Failed Zidovudine Therapy (Release Date: 02/01/1993)

  424. Clinical Alert: Important Therapeutic Information on Treatment of HIV Infection in HIV-Infected Patients Who Are Intolerant of or Have Failed Zidovudine Therapy (Release Date: 02/01/1993)

  425. NIAID RESEARCH ON THE ACQUIRED IMMUNODEFICIENCY SYNDROME (Release Date: 01/29/1993)

  426. Patients' Own Immune Cells Used in Experimental HIV Therapy (Release Date: 01/04/1993)

  427. Relative Benefit of ddI and AZT Depends on Duration of Patients' Previous AZT Use (Release Date: 12/30/1992)

  428. TMP/SMX Better than Aerosolized Pentamidine for Preventing Recurrent PCP (Release Date: 12/23/1992)

  429. First HIV Vaccines Move Into Phase II Testing In Uninfected Volunteers (Release Date: 12/01/1992)

  430. Multi-Site Trial Begins of the Anti-AIDS Drug, Tat Antagonist (Release Date: 11/30/1992)

  431. Switch To ddI From AZT Appears to Slow Progression of HIV Disease (Release Date: 08/26/1992)

  432. Hepatitis (Release Date: 08/01/1992)

  433. Testing AIDS Vaccines: What Do All Those Terms Mean? (Release Date: 07/01/1992)

  434. Early Use of AZT Reduces Risk of Death (Release Date: 04/15/1992)

  435. Summary of Preliminary Analysis of Study Comparing ddI and ZDV (Release Date: 04/13/1992)

  436. Executive Summary: AIDS Research Advisory Committee, National Institute of Allergy and Infectious Diseases (Release Date: 04/01/1992)

  437. Study Shows Promise of Fluconazole for Treatment of AIDS-Related Cryptococcal Meningitis (Release Date: 01/08/1992)

  438. ACTG 106: AZT/ddC Combination Shows Benefits for Patients with Advanced HIV Disease (Release Date: 12/31/1991)

  439. Important Therapeutic Information on Prevention of Recurrent Pneumocystis Carinii Pneumonia in Persons with AIDS (Release Date: 10/11/1991)

  440. Clinical Research on AIDS Vaccines (Release Date: 08/01/1991)

  441. NIAID AIDS RESEARCH: OPPORTUNISTIC INFECTIONS: AIDS-Related Cryptosporidiosis (Release Date: 05/01/1991)

  442. NIAID AIDS RESEARCH: OPPORTUNISTIC INFECTIONS: AIDS-Related Herpes Simplex Virus Infection (Release Date: 05/01/1991)

  443. NIAID AIDS RESEARCH: OPPORTUNISTIC INFECTIONS (Part 2): NIAID-Supported Preclinical and Clinical Research (Release Date: 05/01/1991)

  444. NIAID AIDS RESEARCH: OPPORTUNISTIC INFECTIONS: AIDS-Related Fungal Illnesses (Release Date: 05/01/1991)